CS for CS for CS for SB 1192 Summary

• Physicians prescribing more than a 30-day supply of Schedule II or III controlled substances over a 6-month period for chronic nonmalignant pain must register as controlled substance prescribing practitioners and comply with new standards of practice.

• Physicians at pain management clinics must consult the prescription drug monitoring program database before prescribing Schedule II or III controlled substances, with the Board of Medicine and Board of Osteopathic Medicine authorized to establish penalties for non-compliance.

• Pharmacy permits must commence operations within 180 days of issuance or show good cause; pharmacies must be supervised by a prescription department manager or consultant pharmacist of record at all times.

• Regulation of pharmacies and pharmacists is preempted to the state, prohibiting local ordinances from regulating pharmacies or pharmacists in matters covered under chapter 465; pain management clinic regulation is similarly preempted to the state under specified conditions.

• Prescription drug monitoring program can now be funded by state funds in addition to federal grants and private funding, removing the prior prohibition on manufacturer funding and allowing designated agents under health care practitioner supervision to access the database.